WordNet

located at or near or behind a part or near the end of a structure
of or relating to the pelvis; "pelvic exam"; "pelvic inflammation"
surgical removal of the organs within a body cavity (as those of the pelvis)

PrepTutorEJDIC

《名詞の前にのみ用いて》(生物学的に,位置が)後ろの,後部の / (時間・順序が)後の;(…より)後の《+『to』+『名』》(later) / しり(buttocks)
骨盤の

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 婦人科癌に対する摘除術 exenteration for gynecologic cancer
2. 直腸癌：手術手技 rectal cancer surgical techniques
3. 局所再発性直腸腺癌の治療 treatment of locally recurrent rectal adenocarcinoma
4. 膣癌 vaginal cancer
5. 膀胱切除術後の尿路変更および尿路再建 urinary diversion and reconstruction following cystectomy

English Journal

[A Case of mFOLFOX6-Induced Lactic Acidosis in a Patient with Colon Cancer].

Ito A1, Kawamoto K, Park T, Ito T.
Gan to kagaku ryoho. Cancer & chemotherapy.Gan To Kagaku Ryoho.2014 Nov;41(11):1445-7.
Leucovorin calcium, 5-fluorouracil, and oxaliplatin(FOLFOX)therapy is a standard chemotherapy regimen used to treat colorectal cancer. Peripheral nerve disorder and myelosuppression are frequently reported treatment-related adverse events. With modified FOLFOX6(mFOLFOX6)therapy, adverse events ofan
PMID 25434453

Surgical results of pelvic exenteration in the treatment of gynecologic cancer.

Petruzziello A1, Kondo W, Hatschback SB, Guerreiro JA, Filho FP, Vendrame C, Luz M, Ribeiro R.
World journal of surgical oncology.World J Surg Oncol.2014 Sep 8;12:279. doi: 10.1186/1477-7819-12-279.
BACKGROUND: Our aim in the present study was to evaluate surgical outcomes and complications of pelvic exenteration in the treatment of gynecologic malignancy and to compare surgery-related complications associated with different types of exenteration.METHODS: We performed a retrospective analysis o
PMID 25200866

The role of palliative surgery in castration-resistant prostate cancer.

Piper C1, Porres D, Pfister D, Heidenreich A.
Current opinion in supportive and palliative care.Curr Opin Support Palliat Care.2014 Sep;8(3):250-7. doi: 10.1097/SPC.0000000000000078.
PURPOSE OF REVIEW: Androgen deprivation therapy with luteinising hormone releasing hormone (LHRH) analogues or antagonists represents the treatment of choice in men metastatic prostate cancer (PCA). Depending on the serum concentration of the prostate-specific antigen (PSA) nadir, the survival might
PMID 25090289

Japanese Journal

子宮頸部腺癌ＩＶａ期に対して術前化学療法後に前方または後方骨盤除臓術を施行し長期生存を得た２例

池田ゆうき,鍔本浩志,井上佳代,加藤徹,金澤理一郎,小森慎二,前田弘彰,廣田省三
産婦人科の進歩 63(4), 493-498, 2011
子宮頸部腺癌（腺扁平上皮癌を含む）は扁平上皮癌に比して放射線感受性が低く進行癌では予後が悪い．一方，側方浸潤のないIVa期であれば骨盤除臓術により完全摘出が可能である．当科では1998年～2006年の間，子宮頸部腺癌に対する術前化学療法（NAC: paclitaxel 60mg/m2静脈投与　d1, d8, d15＋cisplatin 70mg/m2経子宮動脈投与およびゼラチンスポン …
NAID 130001890080

子宮頸部腺癌ＩＶａ期に対して術前化学療法後に前方または後方内臓全摘手術を施行し長期生存を得た２例

池田ゆうき,鍔本浩志,井上佳代,坂根理矢,伴知子,細田容子,和田龍,金澤理一郎,小森慎二
産婦人科の進歩 63(3), 362-363, 2011
NAID 130001241804

肛門管への壁内転移が膣直接浸潤を呈した上部直腸癌の1例

水谷聡,塩谷猛,渋谷哲男,松本光司,藤井博昭,森山雄吉
日本消化器外科学会雑誌 36(9), 1336-1341, 2003-09-01
我々は直腸癌が肛門側壁内に転移し,膣へ直接浸潤した症例を経験した.症例は63歳の女性.不正性器出血で婦人科受診し,膣入口部に1.5cm大の隆起性病変を認めた.諸検査後,多発進行直腸癌(上部直腸(Ra),肛門管(P))および子宮・膣直接浸潤,肝転移(H1)の診断で後方骨盤内臓全摘,肝左葉切除術を施行した.組織学的に主病巣(Ra)は中分化型腺癌であった.肛門管の副病変は高度のリンパ管侵襲を伴い,発育形 …
NAID 110001344545

Related Pictures

(PDF) Modified posterior pelvic exenteration for advanced ovarian cancer: ten-year Pelvic exenteration for recurrent gynaecological cancer after radiotherapy Total Pelvic Exenteration - Pelvic Exenteration - Gynecologic Oncology: Clinical TRAM flap construction for total pelvic exenteration combined with Pelvic Exenteration - YouTube (PDF) Modified posterior pelvic exenteration for advanced ovarian cancer: ten-year Ovarian Cancer Cytoreductive Surgery. The Modified Posterior Pelvic Exenteration - YouTube SURGERY4U